首页> 美国卫生研究院文献>BMJ Open >Novel augmented reality solution for improving health literacy around antihypertensives in people living with type 2 diabetes mellitus: protocol of a technology evaluation study
【2h】

Novel augmented reality solution for improving health literacy around antihypertensives in people living with type 2 diabetes mellitus: protocol of a technology evaluation study

机译:新型增强现实解决方案可改善2型糖尿病患者抗高血压药的健康素养:一项技术评估研究方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionLow health literacy is common in people with type 2 diabetes mellitus (T2DM) (up to 40%), associated with decreased self-efficacy in managing T2DM and its important complications, mainly hypertension. This study introduces, for the first time, an easy-to-use solution based on augmented reality (AR) on smartphones, to enhance health literacy around antihypertensive medicines. It assesses the feasibility of the solution for improving health literacy, oriented specifically to angiotensin II receptor blockers; embedding the health literacy improvement into the use cycle of angiotensin II receptor blockers and providing continuous access to information as a form of patient engagement.
机译:简介低健康素养在2型糖尿病(T2DM)患者中很常见(高达40%),与治疗T2DM及其重要并发症(主要是高血压)的自我效能下降相关。这项研究首次引入了基于智能手机上增强现实(AR)的易于使用的解决方案,以增强抗高血压药物的健康素养。它评估了该解决方案改善健康素养的可行性,该解决方案专门针对血管紧张素II受体阻滞剂;将健康素养的改善纳入血管紧张素II受体阻滞剂的使用周期,并以患者参与的形式持续提供信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号